{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:33:57Z","timestamp":1787772837339,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Many biomarkers have now been studied such as C-reactive Protein (CRP), procalcitonin (PCT), etc., and are widely used for the diagnosis of sepsis in clinical practice which may determine the appropriate antibiotic treatment. A flowcytometric cytokine bead array (CBA) assay has now been used to determine multiple interleukins (IL), simultaneously. The aim of this study was to determine the cytokine (IL2, IL4, IL6, IL10, TNF\u03b1, INF\u03b3, and IL17) profiles of interleukins in plasma of sepsis patients by using multiplex Flowcytometric CBA array assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Method<\/jats:title>\n                    <jats:p>s: A total of 99 consecutive patients admitted with the suspected sepsis were studied. PCT concentrations were measured by using the enzyme-linked fluorescent immunoassay (ELFA) technique and flow cytometry-based BD\u2122 CBA Cytokine Kit was used to evaluate levels of 7 cytokines [IL-2, IL-4, IL-6, IL-10, Tumour Necrosis Factor (TNF), Interferon- \u03b3 (IFN-\u03b3), and IL-17A].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Microbiologically defined infection (MDI) demonstrated a positive culture report in 79\/99 (79.7%) of patients. The IL6 [1873.7 (4-5000)] and IL10 [(154.7 (0-1764)] levels were significantly higher in septic patients than those in the negative MDI IL6 [901 (4-5000)] and IL10 [110.4 (4-1372)] levels. The AUROC value of IL6 [0.66 (0.53-0.79)] was found to be the highest among all followed by IL10 [0.65 (0.51-0.79)], IFN\u03b3 [0.63 (0.51-0.77)], PCT [0.61 (0.48-0.75)], and TNF\u03b1 [0.55 (0.42-0.69)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study suggests that that IL6 is substantially more economical and can reduce the investigation cost to half as compared with the procalcitonin assay.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_647_20","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T15:49:45Z","timestamp":1724946585000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic value of different interleukins and procalcitonin in critically ill patients admitted with suspected sepsis"],"prefix":"10.4103","volume":"65","author":[{"given":"Simmi","family":"Mehra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem Kumar","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geet","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati Pabbi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhavi","family":"Rajvanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Govil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240829","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","article-title":"Assessment of the worldwide burden of critical illness: The intensive care over nations (ICON) audit","volume":"2","author":"Vincent","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R2-19-20240829","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1586\/erm.11.26","article-title":"Early diagnosis of sepsis using serum biomarkers","volume":"11","author":"Chan","year":"2011","journal-title":"Expert Rev Mol"},{"key":"R3-19-20240829","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","article-title":"Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis","volume":"7","author":"Tang","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R4-19-20240829","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","article-title":"Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis","volume":"164","author":"Harbarth","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-19-20240829","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diagmicrobio.2012.12.011","article-title":"Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis","volume":"75","author":"Jekarl","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R6-19-20240829","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations","volume":"3","author":"Becker","year":"2008","journal-title":"Crit Care Med"},{"key":"R7-19-20240829","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0188-4409(02)00415-0","article-title":"Predictive value of higher plasma interleukin-6 levels in patients with febrile neutropenia","volume":"33","author":"Karan","year":"2002","journal-title":"Arch Med Res"},{"key":"R8-19-20240829","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10096-006-0143-x","article-title":"Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer","volume":"25","author":"Kitanovski","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R9-19-20240829","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0609.2004.00387.x","article-title":"Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia","volume":"74","author":"Persson","year":"2005","journal-title":"Eur J Haematol"},{"key":"R10-19-20240829","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1469-0691.2011.03490.x","article-title":"Evaluation of Th1\/Th2 cytokines as a rapid diagnostic tool for severe infection in paediatric haematology\/oncology patients by the use of cytometric bead array technology","volume":"17","author":"Tang","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R11-19-20240829","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cmi.2016.09.013","article-title":"Comparison of the diagnostic power of cytokine patterns and procalcitonin for predicting infection among paediatric haematology\/oncology patients","volume":"22","author":"Xia","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R12-19-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep11355","article-title":"Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis","volume":"5","author":"Surbatovic","year":"2015","journal-title":"Sci Rep"},{"key":"R13-19-20240829","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R14-19-20240829","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcrc.2016.01.002","article-title":"The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality","volume":"33","author":"Mat-Nor","year":"2016","journal-title":"J Crit Care"},{"key":"R15-19-20240829","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00003246-200004000-00011","article-title":"Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit","volume":"28","author":"M\u00fcller","year":"2000","journal-title":"Crit Care Med"},{"key":"R16-19-20240829","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s001340051321","article-title":"Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: Diagnostic value and relationship to pro-inflammatory cytokines","volume":"26","author":"Viallon","year":"2000","journal-title":"Intensive Care Med"},{"key":"R17-19-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05382.x","article-title":"An overview of cytokines and cytokine antagonists as therapeutic agents","volume":"1182","author":"Donnelly","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R18-19-20240829","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"R19-19-20240829","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","article-title":"Clinical use of interferon-\u03b3","volume":"1182","author":"Miller","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R20-19-20240829","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12026-007-0045-8","article-title":"Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: Disorders of the interface of innate and adaptive immunity","volume":"38","author":"Holland","year":"2007","journal-title":"Immunol Res"},{"key":"R21-19-20240829","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1749-6632.2009.05075.x","article-title":"Perspective on potential clinical applications of recombinant human interleukin-7","volume":"1182","author":"Sport\u00e8s","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R22-19-20240829","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.2009.05070.x","article-title":"Ustekinumab: Lessons learned from targeting interleukin-12\/23p40 in immune-mediated diseases","volume":"1182","author":"Elliott","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"R23-19-20240829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1749-6632.2009.05074.x","article-title":"Rilonacept\u2014CAPS and beyond: A scientific journey","volume":"1182","author":"Stahl","year":"2009","journal-title":"Ann NY Acad Sci"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_647_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:14:29Z","timestamp":1787771669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_647_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_647_20","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}